abstract |
The present invention relates to new compounds that inhibit Lp-PLA2 activity, to methods for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease , and / or diabetic macular edema (I) (See Formula). |